GlassScriptPhysician profile
Michael D Paula
NPI 1093202699
$17,401.84
in general payments reported to CMS, 2019-2025
40 companies · $3,694 in 2025
The $3,694 reported for 2025 was more than what 91% of Foot & Ankle Surgery providers received nationally (typical 2025 total: $424).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $588 · 2020: $915 · 2021: $602 · 2022: $5,999 · 2023: $3,587 · 2024: $2,017 · 2025: $3,694.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $8,273 · Travel and Lodging: $1,013 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $11.87.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $8,272.74 |
| Travel and Lodging | $1,012.86 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $11.87 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Organogenesis INC. | $4,074.08 | 2020-2025 | Apligraf, Affinity, Puraply Wound Matrix |
| Stryker Corporation | $3,291.92 | 2020-2025 | Inbone, Ortholoc 2 Lapifuse, Gravity |
| Medline Industries LP | $1,318.96 | 2022 | |
| Treace Medical Concepts, INC. | $1,185.98 | 2022-2025 | |
| Abbvie INC. | $738.59 | 2021-2023 | |
| Southern Edge Orthopaedics, INC. | $699.41 | 2019-2025 | |
| Arthrex, INC. | $675.46 | 2023 | |
| Horizon Therapeutics Plc | $655.66 | 2020-2022 | |
| Paratek Pharmaceuticals, INC. | $469.15 | 2022-2025 | Nuzyra |
| Aroa Biosurgery Incorporated | $363.95 | 2023-2025 | |
| Grt US Holding, INC. | $357.23 | 2022 | |
| Averitas Pharma INC. | $345.46 | 2023-2025 | Qutenza |
| Smith+Nephew, INC. | $340.19 | 2021-2025 | Collagenase Santyl, Grafix Pl |
| Urgo Medical North America, LLC | $272.88 | 2023-2025 | Vashe Wound Solution 250 Ml (8.5 Fl Oz) Flip Top Cap, Urgoclean Ag |
| Biotissue Holdings INC. | $267.89 | 2024-2025 |
Show all 40 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Next Science LLC | $241.64 | 2023-2024 | Xperience, Blastx, Surgx |
| Musculoskeletal Transplant Foundation INC. | $222.84 | 2022-2023 | |
| Convatec INC. | $208.07 | 2023-2024 | |
| Innovation Technologies INC | $198.87 | 2025 | Irrisept |
| Medical Device Business Services, INC. | $177.25 | 2020 | |
| Sanara Medtech INC. | $165.91 | 2022 | |
| Bioventus LLC | $148.91 | 2022-2025 | Exogen Ultrasound Bone Healing System |
| Polynovo North America LLC | $137.25 | 2022-2025 | Novosorb Btm |
| Integra Lifesciences Corporation | $134.35 | 2022 | |
| Paragon 28, INC. | $121.40 | 2020 | |
| Kci USA, INC. | $99.96 | 2022 | |
| Ets Wound Care LLC | $99.52 | 2023-2025 | Mirragen Advanced Wound Matrix |
| Acera Surgical, INC. | $68.99 | 2022 | |
| Abbott Laboratories | $46.23 | 2023-2024 | Proclaim |
| Acumed LLC | $38.05 | 2022 | |
| Solventum Corporation | $34.27 | 2024-2025 | 3m Cavilon, Kerramax Care, Activ.A.C. |
| Depuy Synthes Sales INC. | $26.69 | 2024 | Fibulink |
| Reprise Biomedical, INC. | $25.44 | 2024 | Miro3d |
| Medtronic, INC. | $23.52 | 2025 | Intellis Adaptivestim |
| Access Pro Medical, LLC | $22.56 | 2025 | Matriderm |
| Alfasigma USA, INC. | $22.36 | 2022 | |
| Melinta Therapeutics, LLC | $22.32 | 2022 | |
| Zimmer Biomet Holdings, INC. | $21.61 | 2021 | |
| Kerecis Limited | $21.06 | 2024 | Kerecis Omega3 Marigen, Kerecis Omega3 Graftguide, Kerecis Omega3 Surgiclose |
| Mimedx Group, INC. | $15.96 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Paula listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.